Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.
2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10
52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,817 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,06,59351.5% delivered
Wockhardt share news and announcements
1,014 announcements, routine notices left out, newest first. Page 6 of 21.
Oct 2021
11 Oct · News Verification
The exchange asked on 8 Oct 2021
Sep 2021
30 Sep · Rating
3 Sep · Disclosure
3 Sep · Rating
2 Sep · Disclosure
Aug 2021
27 Aug · Disclosure
23 Aug · Disclosure
16 Aug · Disclosure
Jul 2021
23 Jul · Disclosure
22 Jul · Results
22 Jul · Board meeting
15 Jul · Board meeting
9 Jul · Updates
5 Jul · Legal
Exchange has sought clarification from Wockhardt Limited with respect to announcement dated 03-Jul-2021, regarding 'Incorporation of a subsidiary of Wockhardt Limited ( the Company ) - Wockhardt Biologics Limited. On basis of above the Company is required to clarify following: 1. Industry to which the entity being acquired belongs;The response of the Company is awaited.
Jun 2021
23 Jun · Disclosure
May 2021
31 May · News Verification
The exchange asked on 28 May 2021
31 May · Disclosure
27 May · Results
27 May · Board meeting
24 May · Disclosure
Apr 2021
6 Apr · Rating
Mar 2021
21 Mar · Board meeting
Not held on this date